Scientists Have Discovered A New Method Of Detecting Cancer.
A unexplored check marketed as an other to a mammogram for breast cancer detection is not an real screening TOOL, US health officials say. With the nipple aspirate test, a teat pump collects mobile from a woman's nipple. The fluid is then examined for perverse and potentially cancerous cells for more. The test is advertised as easier, more self-satisfied and less painful than mammograms.
However, there is no proof to support claims that the trial can detect breast cancer, said Dr David Lerner, a medical office-holder at the US Food and Drug Administration and a soul imaging specialist discover more. "FDA's concern is that the nipple aspirate assay is being touted as a standalone tool to screen for and analyse breast cancer as an alternative to mammography," Lerner said in an mechanism news release.
So "Our fear is that women will forgo a mammogram and have this evaluation instead". Skipping a mammogram could put a woman's vigorousness and life at risk if breast cancer goes undetected, Lerner warned goat weed pharmacy. He said there is no systematic evidence that the nipple aspirate test, when occupied on its own, is an effective screening tool for tit cancer or any other medical condition.
The test is still being studied to determine if it might be beneficial in combination with other methods to screen for disease. "The bottom line is that women should not rely solely on these nipple aspirate tests for the screening or diagnosis of knocker cancer. Mammography is still the gold standard".
In October, 2013, Atossa Genetics pulled its nipple aspirate probe - called the ForeCYTE Breast Health Test - off the vend after being warned by the FDA that its claims about the exam were unsubstantiated. The associates claimed the prove was "literally a Pap spread for breast cancer". Pap smears are a standard try for cervical cancer.
And Women who have had a nipple aspirate test as a cultivate of breast cancer screening should also have a mammogram, according to screening guidelines or as recommended by their doctor. Also, they should hot air to their doctor about whether additional tests are needed, the FDA said. One in eight US women will improve titty cancer in her lifetime continue. The disease is the younger leading cancer killer of women in the country.
No comments:
Post a Comment